Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(29%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_2
2
29%
Ph phase_1
2
29%
Ph not_applicable
1
14%
Ph early_phase_1
2
29%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
2(28.6%)
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(3)
Other(2)

Detailed Status

Completed3
Recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (28.6%)
Phase 12 (28.6%)
Phase 22 (28.6%)
N/A1 (14.3%)

Trials by Status

recruiting229%
completed343%
unknown229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7